Phase II study of OSI-774 (erlotinib, Tarceva) in elderly patients with advanced stage or inoperable non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Dec 2005 New trial record.